• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10623
Device Problem Obstruction of Flow (2423)
Patient Problems Atherosclerosis (1728); Reocclusion (1985)
Event Date 11/16/2020
Event Type  Injury  
Event Description
(b)(6) registry.It was reported that in-stent restenosis occurred.In (b)(6) 2020, the subject presented with unstable angina.Subsequently, the subject was referred for cardiac catheterization and on the same day, the index procedure was performed.The target lesion was located in the proximal left anterior descending artery (lad) with 70% stenosis and was 35 mm long, with a reference vessel diameter of 3.0 mm.The lesion was treated with pre-dilatation and placement of a 3.00mmx38 mm synergy stent system.Following post dilatation, residual stenosis was 0%.Two days later, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2020, the subject presented with symptoms of coronary atherosclerotic heart disease and was hospitalized for further evaluation and treatment.The subject was diagnosed with coronary atherosclerotic heart disease.The following day, coronary angiography revealed 95% stenosis in proximal lad which had previously placed study device and it was treated with percutaneous coronary intervention (target vessel revascularization).Post intervention, residual stenosis was 0%.At the time of reporting, the event was considered to be recovering/resolving.One day post intervention, the subject was discharged on aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10988241
MDR Text Key220896390
Report Number2134265-2020-17381
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/24/2020
Device Model Number10623
Device Catalogue Number10623
Device Lot Number0023899954
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/04/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/29/2019
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age53 YR
-
-